Growth Factor/Peptide Receptor Imaging for the Development of Targeted Therapy in Oncology

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|31|3340-3347

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.31, 2008-11, pp. : 3340-3347

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Development of Inhibitors of the Insulin-like Growth Factor Receptor in Oncology

By  

Current Drug Targets, Vol. 10, Iss. 10, 2009-10 ,pp. : 923-936

Bentham Science Publishers

Access to resources Recommend Favorite

Nuclear Imaging of Prostate Cancer with Gastrin-Releasing-Peptide- Receptor Targeted Radiopharmaceuticals

By  

Current Pharmaceutical Design, Vol. 14, Iss. 28, 2008-10 ,pp. : 3033-3047

Bentham Science Publishers

Access to resources Recommend Favorite

Investigation of cancer cell lines for peptide receptor-targeted drug development

By Sun Lichun   Luo Jing   Mackey L. Vienna   Morris Lynsie M.   Franko-Tobin Laura G.   LePage Keith T.   Coy David H.  

Journal of Drug Targeting, Vol. 19, Iss. 8, 2011-09 ,pp. : 719-730

Informa Healthcare

Access to resources Recommend Favorite

Development of Vascular Endothelial Growth Factor Receptor (VEGFR) Kinase Inhibitors as Anti-Angiogenic Agents in Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 11, Iss. 6, 2004-03 ,pp. : 731-745

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer therapies targeted to the epidermal growth factor receptor and its family members

By Kane Susan E  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 2, 2006-02 ,pp. : 147-164

Informa Healthcare

Access to resources Recommend Favorite